Corneal damage causes significant vision loss, second only to cataracts. Corneal replacement is a developing technology that is becoming a necessity for many patients due to disease (e.g., herpes infection), complications from LASIK, hereditary problems (e.g., Fuch's disease) and complications from related surgeries (e.g., cataracts). Current strategies employed for corneal grafting primarily make use of synthetic or allergenic materials. While these strategies are partially effective, the downside is that they can stimulate host immune responses resulting in tissue rejection or carry the risk of transferring diseases from unhealthy donor organs. These complications are compounded by the growing use of corrective eye surgery which renders corneas unsuitable for grafting, further reducing the availability of acceptable allergenic supplies. The development of a human cornea replacement that alleviates these shortcomings is urgently needed and this is the goal of the proposed program. The hypothesis is that silk protein-biomaterial lamellar systems coupled with cornea- specific cells can be bioengineered to match in vivo corneal properties and meet functional requirements. The proposed system will exploit the novel material and biological features of silk, including surface micropatterning to guide cells and extracellular matrix deposition, slow degradation, biocompatibility, optical transparency and mechanical durability for handling, suturing and tolerating ocular pressures. A cornea tissue system that slowly degrades to allow for host native tissue replacement would offer a significant and novel advancement in corneal transplantation technology. In combination with corneal derived stem cells, we anticipate optimizing cell-silk interactions first in 2D and then as 3D lamellar structures. Functional assessments of the performance of these cornea tissue systems (mechanical, optical) will follow as will optimization of surgical methods and host integration. The outcome of the proposed program will be the in vitro optimization of human cornea replacements and in vivo assessments of utility. The research team has the required background with the materials, cells and systems of study to support the program plans, and the data collected during our R21 program provides supporting documentation for all aspects of the proposed study. Our approach to addressing this need is unique and offers novel methodology to meet the ever-growing demands for corneal replacements. Successful development of an in vitro source will ameliorate the current shortages and provide a much-needed alternative for patients.

Public Health Relevance

Corneal diseases are responsible for extensive vision loss throughout the world, second only to cataracts. A number of sources are currently available for cornea replacement and include allergenic and synthetic materials. However, each of these options has problems, including disease transmission;inflammatory responses post implantation and poor material performance that may result in tissue rejection or device failure. These concerns are compounded by the growing demand for corrective surgery which renders would-be donor corneas unsuitable for grafting. Thus, a crucial need exists to develop new cornea replacement devices that provide the required material and biological properties to address the above limitations, while also offering an integration strategy that allows the device to be replaced by the patients'native tissues.

Agency
National Institute of Health (NIH)
Institute
National Eye Institute (NEI)
Type
Research Project (R01)
Project #
5R01EY020856-04
Application #
8511657
Study Section
Biomaterials and Biointerfaces Study Section (BMBI)
Program Officer
Mckie, George Ann
Project Start
2010-08-01
Project End
2014-07-31
Budget Start
2013-08-01
Budget End
2014-07-31
Support Year
4
Fiscal Year
2013
Total Cost
$351,082
Indirect Cost
$123,082
Name
Tufts University
Department
Engineering (All Types)
Type
Schools of Engineering
DUNS #
073134835
City
Medford
State
MA
Country
United States
Zip Code
02155
Tokareva, Olena; Jacobsen, Matthew; Buehler, Markus et al. (2014) Structure-function-property-design interplay in biopolymers: spider silk. Acta Biomater 10:1612-26
Wu, Jian; Rnjak-Kovacina, Jelena; Du, Yiqin et al. (2014) Corneal stromal bioequivalents secreted on patterned silk substrates. Biomaterials 35:3744-55
Partlow, Benjamin P; Hanna, Craig W; Rnjak-Kovacina, Jelena et al. (2014) Highly tunable elastomeric silk biomaterials. Adv Funct Mater 24:4615-4624
Wang, Qin; Xia, Xiaoxia; Huang, Wenwen et al. (2014) High Throughput Screening of Dynamic Silk-Elastin-Like Protein Biomaterials. Adv Funct Mater 24:4303-4310
Tokareva, Olena; Michalczechen-Lacerda, Valquiria A; Rech, Elibio L et al. (2013) Recombinant DNA production of spider silk proteins. Microb Biotechnol 6:651-63
Zarbin, Marco A (2013) Accelerated in vitro degradation of optically clear low-? sheet silk films by enzyme-mediated pretreatment. JAMA Ophthalmol 131:676
Guziewicz, Nicholas A; Massetti, Andrew J; Perez-Ramirez, Bernardo J et al. (2013) Mechanisms of monoclonal antibody stabilization and release from silk biomaterials. Biomaterials 34:7766-75
Hu, Xiao; Park, Sang-Hyug; Gil, Eun Seok et al. (2011) The influence of elasticity and surface roughness on myogenic and osteogenic-differentiation of cells on silk-elastin biomaterials. Biomaterials 32:8979-89
Karve, Kiran A; Gil, Eun Seok; McCarthy, Stephen P et al. (2011) Effect of ?-sheet crystalline content on mass transfer in silk films. J Memb Sci 383:44-49
Xia, Xiao-Xia; Xu, Qiaobing; Hu, Xiao et al. (2011) Tunable self-assembly of genetically engineered silk--elastin-like protein polymers. Biomacromolecules 12:3844-50

Showing the most recent 10 out of 11 publications